蘇州俞氏藥業(yè)有限公司
Suzhou Yushi Pharmaceutical Co., Ltd.
Comprehensive pharmaceutical company
Production of Chinese patent medicine preparations and chemical medicine preparations as a whole
PRODUCTS
■ Amlodipine Besylate Tablets instr
■ Lansoprazole Enteric-coated Capsu
■ Fluoxetine Hydrochloride Capsules
■ Roxithromycin Dispersible Tablets
■ Nimesulide Granules instructions
■ Azithromycin Dispersible Tablets
■ Simvastatin Tablets instructions
■ Azithromycin Granules instruction
■ Fluconazole Capsules instructions
NEWS
YUSHI Pharmaceutical
The proportion of chemical drug preparation exports is limited, and international competitiveness needs to be improved
Time: 2021-08-18
[Market Analysis of China Pharmaceutical Network] According to the "China's Chemical Pharmaceutical Preparation Industry Production and Sales Demand and Investment Forecast Analysis Report" data released by the Qianzhan Industry Research Institute, my country's chemical pharmaceutical preparation exports have exceeded US$3 billion in recent years, and the year-on-year growth rate has remained around 40%. , The types of export products are also increasing.
(The proportion of chemical drug preparation exports is limited, and international competitiveness needs to be improved. Picture source: Baidu picture)
For a long time, my country's chemical drug preparation products have frequently encountered the problem of "going to sea", and the main export force is still raw materials. It is only in recent years that the export value of chemical pharmaceutical preparations has seen rapid growth, but the proportion is still limited. In the future, it is necessary to further improve international competitiveness and win more overseas market shares.
The so-called chemical preparations refer to chemical preparations directly used for the prevention and diagnosis of human diseases, and generally belong to the same category as western medicine preparations and western patent medicines. After years of development, my country's chemical drug preparation production technology has made rapid progress. While meeting domestic supply, it continues to conquer cities and land overseas, and its export volume is rising steadily.
Chemical preparations
According to the "China's chemical pharmaceutical preparation industry production and sales demand and investment forecast analysis report" data released by the Qianzhan Industry Research Institute, my country's chemical pharmaceutical preparations export volume has exceeded 3 billion US dollars in recent years, with a year-on-year growth rate of about 40%, and the types of export products are also increasing. .
However, on the whole, there are still many difficulties for chemical preparations to go abroad, and there is a long way to go in the future.
First of all, it is more difficult to register abroad. This is because chemical drug preparations directly act on patients, which require higher quality standards and entry barriers, and the registration procedures are cumbersome. It usually takes 3-4 years or even longer for the entire registration procedure to come down, leading to greater risks for companies and low export willingness.
Secondly, the scientific research and development capabilities are insufficient. At present, most of the chemical preparations exported by my country are generic drugs, and the added value of the products is low, making it difficult to build an international brand. The blame is due to insufficient investment in R&D and lack of resources for new drug research.
Finally, the export variety is single. In fact, my country has long become a major producer of raw materials in the world, but due to technical limitations, the types of products that can be exported are limited, concentrated in artemisinins, cephalosporins, vitamins, hormones and other drugs.
Therefore, in order to expand the export of chemical pharmaceutical preparations and improve international competitiveness. The first is to speed up international certification and break the bottleneck in the export of pharmaceutical preparations. To obtain international certification, it is necessary to start from within itself and raise the level in terms of cultivating talents, building high-standard workshops, and implementing production in accordance with foreign requirements.
The second is to improve the variety of preparations and make full use of the existing advantages of R&D, management, and operation of APIs. Leveraging on the advantages of raw materials and improving the variety of preparations can better expand business in the international market.
The third is to strengthen independent innovation capabilities and vigorously develop local brands. Independent innovation is the fundamental way for chemical preparation companies to go abroad and join international competition. Since the development of the chemical pharmaceutical preparation industry, it is necessary to gradually get rid of the imitation model, highlight independent innovation, and integrate technical resources in order to create a local pharmaceutical brand.
(Source: Qianzhan Industry Research Institute Author: Wen Chenghui Original title: Chemical pharmaceutical preparations are difficult to "go to sea" and international competitiveness needs to be improved in the future)
HOME | ABOUT US | FACTORY | PRODUCTS | NEWS | ORDER | CONTACT | 中文版
Copyright(C)2021, Suzhou Yushi Pharmaceutical Co., Ltd. All Rights Reserved. Supported by ChinaChemNet ChemNet Toocle Copyright Notice 備案序號:蘇ICP備2022049504號